KB7.F Solventum Corporation

Healthcare Medical Instruments & Supplies Frankfurt Exchange
79.00 EUR
Close of Nov 12, 2026
53.60 81.80
Market cap
EUR 13.4B
P/E
102.6x
P/B
3.17x
ROE
2.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is KB7.F undervalued?

Graham number

The Graham number of Solventum Corporation cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Solventum Corporation fundamental analysis

No fundamental analysis for Solventum Corporation yet.

Solventum Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Solventum Corporation

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, steriliz…

Full company profile